Institutional Review Board Statement
The study was approved by the Hamilton Health Sciences Integrated Research Ethics Board (HIREB-5754), conformed to the guidelines outlined in the Declaration of Helsinki, and complied with the guidelines set out in the Canadian Tri-Council policy statement on ethical conduct for research involving humans. The trial was registered at clinicaltrials.gov (NCT03812211). The study was conducted under Good Clinical Practice (GCP) guidelines.